Brickell Biotech Inc

-0.01 (-3.03%)
Earnings Announcements

Brickell Biotech Reports Q1 2022 Results And Provides Corporate Update

Published: 05/12/2022 20:10 GMT
Brickell Biotech Inc (BBI) - Brickell Biotech Reports First Quarter 2022 Financial Results and Provides Corporate Update.
Brickell Biotech- Expects Cash, Cash Equivalents As of March 31, 2022,payments Under Deal With Botanix to Support Operations for at Least Next 12 Months.
Brickell Biotech Inc - Qtrly Loss per Share $0.08.
Revenue is expected to be $2.38 Million
Adjusted EPS is expected to be -$0.04

Next Quarter Revenue Guidance is expected to be $0.33 Million
Next Quarter EPS Guidance is expected to be -$0.05

More details on our Analysts Page.